Histochemistry and morphometric analysis of muscle fibers from Patients with Duchenne Muscular Dystrophy(DMD);Histoquímica y Análisis Morfométrico de las Fibras Musculares de Pacientes con Distrofia Muscular de Duchenne(DMD)

International Journal of Morphology

Volumn 29, Issue 3, 2011, Pages 934-938

  Cavalcanti, George Maciel ^a   Oliveira, André de Sá Braga ^a   Assis, Thiago de Oliveira ^a   Chimelli, Leila Maria Cardão ^b   de Medeiros, Paloma Lys ^a   de Mota, Diógenes Luís ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Duchenne muscular dystrophy; Histochemistry analysis; Morphometric analysis; Vastus lateralis muscle

Indexed keywords

EID: 80155131452     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022011000300046     Document Type: Article

References (18)

1. Adams, R. D.; Victor, M. & Ropper, A. H. Distrofias Musculares. 6a ed. Santiago, McGraw-Hill Interamericana, 1997.
2. Brooke, M. H. & Engel, W. K. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology, 19(6):591-605, 1969.
3. Brooke, M. H. Kaiser, K. K. Muscle fiber types: how many and what kind? Arch. Neurol., 23(4):369-79, 1970.
4. Day, J. W. Ranum, L. P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul. Disord., 15(1):5-16, 2005.
5. Dubowitz, V. Brooke, M. H. Muscle Biopsy: A Practical Approach. 2nd ed. London, Philadelphia & Toronto, W. B. Saunders, 1985.
6. El-Harouni, A. A.; Amr, K. S.; Effat, L. K.; Eassawi, M. L.; Ismail, S.; Gad, Y. Z. & El-Awady, M. K. The milder phenotype of the dystrophin gene double deletions. Acta Neurol. Scand., 107(6):400-4, 2003.
7. Emery, A. E. Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul. Disord., 1(1):19-29, 1991.
8. Emery, A. E. Duchenne muscular dystrophy. 2nd ed. Oxford and New York, University Press, 1993.
9. Jay, V. Vajsar, J. The dystrophy of Duchenne. Lancet, 357(9255):550-2, 2001.
10. Kapsa, R.; Kornberg, A. J. Byrne, E. Novel therapies for Duchenne muscular dystrophy. Lancet Neurol., 2(5):299- 310, 2003.
11. Koenig, M.; Beggs, A. H.; Moyer, M.; Scherpf, S.; Heindrich, K.; Bettecken, T.; Meng, G.; Müller, C. R.; Lindlöf, M. Kaariainen, H. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am. J. Hum. Genet., 45(4):498-506, 1989.
12. Muntoni, F.; Torelli, S. Fernili, A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol., 2(12):731-40, 2003.
13. Piccininni, M.; Falsini, C. Pizzi, A. Quality of life in hereditary neuromuscular diseases. Acta Neurol. Scand., 109(2):113-9, 2004.
14. Simoneau, J. A. Bouchard, C. Human variation in skeletal muscle fiber-type proportion and enzyme activities. Am. J. Physiol., 257(4 Pt 1):E567-72, 1989.
15. Toop, J. Emery, A. E. Muscle histology in fetuses at risk for Duchenne muscular dystrophy. Clin. Genet., 5(3):230-3, 1974.
16. Worton, R. Muscular dystrophies: diseases of the dystrophinglycoprotein complex. Science, 270(5237):755-6, 1995.
17. Zats, M.; Frota-Pessoa, O.; Levy, J. A. Peres, E. A. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study. J. Genet. Hum., 24(2):153-68, 1976.
18. Zats, M. A biologia molecular contribuindo para a compreensão e prevenção das doenças hereditárias. Ciênc. Saúde Coletiva, 7(1):85-99, 2002.